Product Code: BMIRE00030382
The Asia Pacific rapid test kit market was valued at US$ 3,836.99 million in 2022 and is expected to reach US$ 5,935.28 million by 2030; it is estimated to record a CAGR of 5.6% from 2022 to 2030.
Increasing Preference for PCR Techniques Drives Asia Pacific Rapid Test Kit Market
In recent years, molecular methods such as PCR have evolved as more effective diagnostic tools, as they aid in the precise diagnosis of a wide range of infectious diseases. Most of the popular molecular tests use reverse transcription polymerase chain reaction (RT-PCR). The technique provides reproducible results that are comparable between different laboratories and hence are accepted worldwide. The manufacturers are involved in new PCR developments.
For instance, GeneSoC is a recently developed system in which the PCR reaction solutions are reciprocally driven over numerous preheated zones and encapsulated on a chip within an extremely thin flow channel. GeneSoC is available for multiplex real-time PCR and is capable of concurrently detecting 3 fluorescence channels. It is regarded as an excellent alternative diagnostic technology for the detection of influenza A and B viruses, as it completes the real-time RT-PCR reaction in ~16 minutes. PCR techniques are also being widely accepted and utilized in emerging countries. According to a report by the World Health Organization on the Establishment of PCR Laboratory in Developing Countries 2016, WHO provides necessary technical assistance to establish PCR laboratories in all 11 WHO Southeast Asia countries. These facilities have adopted different PCR technologies such as RT-PCR, multiplex PCR, real-time PCR, in-situ PCR, and dPCR, depending on their needs. The application of PCR technologies is also increasing in clinical microbiology, virology, parasitology, biotechnology, and allied fields due to the simple, rapid, and highly specific screening enabled by this tool. Thus, the growing preference for PCR as a diagnostic and clinical tool is expected to provide lucrative opportunities to the rapid test kits market during the forecast period.
Asia Pacific Rapid Test Kit Market Overview
The World Health Organization considers HIV self-testing (HIVST) to be a legitimate alternative to standard HIV testing performed in diagnostic laboratories. Over the last five years, the healthcare sector and authorities in China have strived to gradually increase the extent of HIVST use. The coverage of HIV testing can be further increased with the help of HIVST to identify the condition among individuals living with HIV but are ignorant of their infection. The Chinese government emphasizes on the rapidly rising HIVST rate among homosexual men. The country has been exploring strategies to promote HIV self-testing through selling HIVST kits in pharmacies and online, according to the State Council of China, which released the "Thirteenth Five-Year Plan (2017-2022)" for HIV prevention and control in 2017.
Asia Pacific Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)
Asia Pacific Rapid Test Kit Market Segmentation
The Asia Pacific rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Asia Pacific rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.
In terms of product, the Asia Pacific rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.
By technology, the Asia Pacific rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.
Based on application, the Asia Pacific rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.
In terms of end user, the Asia Pacific rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.
Based on country, the Asia Pacific rapid test kit market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific rapid test kit market share in 2022.
F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, SD Biosensor Inc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Asia Pacific rapid test kit market.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
4. Asia Pacific Rapid Test Kits Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Prevalence of Genetic and Infectious Diseases
- 4.1.2 Strategic Initiatives by Manufacturers
- 4.2 Market Restraints
- 4.2.1 Uncertainties Related to Accuracy of Results
- 4.3 Market Opportunities
- 4.3.1 Increasing Preference for PCR Techniques
- 4.4 Future Trends
- 4.4.1 Innovations in Rapid Antigen Tests
- 4.5 Impact Analysis
5. Rapid Test Kits Market - Asia Pacific Market Analysis
- 5.1 Overview
- 5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. Asia Pacific Rapid Test Kits Market Analysis - by Type
- 6.1 Overview
- 6.2 Rapid Antigen Testing
- 6.2.1 Overview
- 6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 6.3 Rapid Antibody Testing
- 6.3.1 Overview
- 6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 6.4 Others
- 6.4.1 Overview
- 6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Rapid Test Kits Market Analysis - by Product
- 7.1 Overview
- 7.2 Over-the-Counter Rapid Testing Kit
- 7.2.1 Overview
- 7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 7.3 Professional Rapid Testing Kit
- 7.3.1 Overview
- 7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Rapid Test Kits Market Analysis - by Technology
- 8.1 Overview
- 8.2 Lateral Flow Assay
- 8.2.1 Overview
- 8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 8.3 Solid Phase
- 8.3.1 Overview
- 8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 8.4 Agglutination
- 8.4.1 Overview
- 8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 8.5 Immunospot Assay
- 8.5.1 Overview
- 8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 8.6 Cellular-Component Based
- 8.6.1 Overview
- 8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Rapid Test Kits Market Analysis - by Application
- 9.1 Overview
- 9.2 Blood Glucose Testing
- 9.2.1 Overview
- 9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3 Infectious Disease Testing
- 9.3.1 Overview
- 9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
- 9.4 Cardiometabolic Testing
- 9.4.1 Overview
- 9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 9.5 Pregnancy and Fertility
- 9.5.1 Overview
- 9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Rapid Test Kits Market Analysis - by End User
- 10.1 Overview
- 10.2 Hospital and Clinics
- 10.2.1 Overview
- 10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 10.3 Diagnostic Centers
- 10.3.1 Overview
- 10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 10.4 Home-Care
- 10.4.1 Overview
- 10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 10.5 Others
- 10.5.1 Overview
- 10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. Asia Pacific Rapid Test Kits Market - Country Analysis
- 11.1 Asia Pacific
- 11.1.1 Asia Pacific: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
- 11.1.1.1 China
- 11.1.1.2 China: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.1.2.1 China: Rapid Test Kits Market Breakdown, by Type
- 11.1.1.2.2 China: Rapid Test Kits Market Breakdown, by Product
- 11.1.1.2.3 China: Rapid Test Kits Market Breakdown, by Technology
- 11.1.1.2.4 China: Rapid Test Kits Market Breakdown, by Application
- 11.1.1.2.4.1 China: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
- 11.1.1.2.5 China: Rapid Test Kits Market Breakdown, by End User
- 11.1.1.3 Japan
- 11.1.1.4 Japan: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.1.4.1 Japan: Rapid Test Kits Market Breakdown, by Type
- 11.1.1.4.2 Japan: Rapid Test Kits Market Breakdown, by Product
- 11.1.1.4.3 Japan: Rapid Test Kits Market Breakdown, by Technology
- 11.1.1.4.4 Japan: Rapid Test Kits Market Breakdown, by Application
- 11.1.1.4.4.1 Japan: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
- 11.1.1.4.5 Japan: Rapid Test Kits Market Breakdown, by End User
- 11.1.1.5 India
- 11.1.1.6 India: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.1.6.1 India: Rapid Test Kits Market Breakdown, by Type
- 11.1.1.6.2 India: Rapid Test Kits Market Breakdown, by Product
- 11.1.1.6.3 India: Rapid Test Kits Market Breakdown, by Technology
- 11.1.1.6.4 India: Rapid Test Kits Market Breakdown, by Application
- 11.1.1.6.4.1 India: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
- 11.1.1.6.5 India: Rapid Test Kits Market Breakdown, by End User
- 11.1.1.7 Australia
- 11.1.1.8 Australia: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.1.8.1 Australia: Rapid Test Kits Market Breakdown, by Type
- 11.1.1.8.2 Australia: Rapid Test Kits Market Breakdown, by Product
- 11.1.1.8.3 Australia: Rapid Test Kits Market Breakdown, by Technology
- 11.1.1.8.4 Australia: Rapid Test Kits Market Breakdown, by Application
- 11.1.1.8.4.1 Australia: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
- 11.1.1.8.5 Australia: Rapid Test Kits Market Breakdown, by End User
- 11.1.1.9 South Korea
- 11.1.1.10 South Korea: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.1.10.1 South Korea: Rapid Test Kits Market Breakdown, by Type
- 11.1.1.10.2 South Korea: Rapid Test Kits Market Breakdown, by Product
- 11.1.1.10.3 South Korea: Rapid Test Kits Market Breakdown, by Technology
- 11.1.1.10.4 South Korea: Rapid Test Kits Market Breakdown, by Application
- 11.1.1.10.4.1 South Korea: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
- 11.1.1.10.5 South Korea: Rapid Test Kits Market Breakdown, by End User
- 11.1.1.11 Rest of Asia Pacific
- 11.1.1.12 Rest of Asia Pacific: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
- 11.1.1.12.1 Rest of Asia Pacific: Rapid Test Kits Market Breakdown, by Type
- 11.1.1.12.2 Rest of Asia Pacific: Rapid Test Kits Market Breakdown, by Product
- 11.1.1.12.3 Rest of Asia Pacific: Rapid Test Kits Market Breakdown, by Technology
- 11.1.1.12.4 Rest of Asia Pacific: Rapid Test Kits Market Breakdown, by Application
- 11.1.1.12.4.1 Rest of Asia Pacific: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
- 11.1.1.12.5 Rest of Asia Pacific: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in the Rapid Test Kit Market
- 12.3 Inorganic Growth Strategies
- 12.4 Organic Growth Strategies
13. Company Profiles
- 13.1 F. Hoffmann-La Roche Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Becton Dickinson and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 ARKRAY Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 Fujirebio Europe NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 bioMerieux SA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Cepheid
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Meril Life Sciences Pvt Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 QIAGEN NV
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 OraSure Technologies Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Guangzhou Wondfo Biotech Co Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 13.11 Denka Co Ltd
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
- 13.12 Abbott Laboratories
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
- 13.13 SD Biosensor Inc
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
- 13.14 Bio-Rad Laboratories Inc
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
- 13.15 Hologic Inc
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
- 13.16 DiaSorin SpA
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
- 13.17 Premier Medical Corp Pvt Ltd
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
- 13.18 Beckman Coulter Inc
- 13.18.1 Key Facts
- 13.18.2 Business Description
- 13.18.3 Products and Services
- 13.18.4 Financial Overview
- 13.18.5 SWOT Analysis
- 13.18.6 Key Developments
14. Appendix
- 14.1 About The Insight Partners